Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Invesco S&P SmallCap Health Care ETF (PSCH) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Invesco S&P SmallCap Health Care ETF (PSCH) - free report >>
Image: Bigstock
Small-Cap Health Care ETF (PSCH) Hits New 52-Week High
For investors looking for momentum, Invesco S&P SmallCap Health Care ETF (PSCH - Free Report) is probably a suitable pick. The fund just hit a 52-week high — up roughly 94.99% from its 52-week low of $83.54/share.
Does it have more gains in store? Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
PSCH in Focus
The underlying S&P SmallCap 600 Capped Health Care Index measures the overall performance of common stocks in the health care sector. The fund charges 29 bps in fees (see all Technology ETFs here).
Why the Move?
Increasing health care spending, flurry of positive clinical trials, FDA approvals, the rise of genomics, digital innovation in healthcare, solid M&A and IPO activities have been pushing the space higher.
More Gains Ahead?
The fund has a positive weighted alpha of 41.20, which gives cues of further rally.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>